2026 AARP Medicare Rx Preferred from UHC (PDP) formulary (drug list)
Contract S5921, plan 411 · Oregon · 3,518 drugs on file · formulary ID 00026000. Each drug links to its cost in every CMS PDP Region 30 plan.
124 drugs starting with R.
| Drug name | Tier | 30-day preferred pharmacy | 90-day mail order | Usage management |
|---|---|---|---|---|
| RABAVERT KitRabies Vaccine | 3Preferred Brand | 16% | 16% |
|
| RABEPRAZOLE SODIUM 20 mg Tablet, Delayed Release | 3Preferred Brand | 16% | 16% | None |
| RADICAVA ORS KitEdaravone | 5Specialty Tier | 31% | N/A |
|
| RALDESY TM 10 mg/mL SolutionTrazodone Hydrochloride Oral | 5Specialty Tier | 31% | N/A | None |
| RALOXIFENE HYDROCHLORIDE 60 mg Tablet, Film Coated | 3Preferred Brand | 16% | 16% |
|
| RAMELTEON 8 mg Tablet | 4Non-Preferred Drug | 37% | N/A |
|
| RAMIPRIL 1.25 mg Capsule | 1Preferred Generic | $5.00 | $0.00 | None |
| RAMIPRIL 10 mg Capsule | 1Preferred Generic | $5.00 | $0.00 | None |
| RAMIPRIL 2.5 mg Capsule | 1Preferred Generic | $5.00 | $0.00 | None |
| RAMIPRIL 5 mg Capsule | 1Preferred Generic | $5.00 | $0.00 | None |
| RANOLAZINE 1000 mg Tablet, Extended Release | 3Preferred Brand | 16% | 16% |
|
| RANOLAZINE 500 mg Tablet, Extended Release | 3Preferred Brand | 16% | 16% |
|
| RASAGILINE .5 mg Tablet | 4Non-Preferred Drug | 37% | N/A | None |
| RASAGILINE 1 mg Tablet | 4Non-Preferred Drug | 37% | N/A | None |
| RAYALDEE 30 ug Capsule, Extended ReleaseCalcifediol | 5Specialty Tier | 31% | N/A |
|
| RECLIPSEN 28 DAY KitDesogestrel And Ethinyl Estradiol | 3Preferred Brand | 16% | 16% | None |
| RECOMBIVAX HB 10 ug/mL Injection, SuspensionHepatitis B Vaccine (Recombinant) | 3Preferred Brand | 16% | 16% |
|
| RECOMBIVAX HB 10 ug/mL Injection, SuspensionHepatitis B Vaccine (Recombinant) | 3Preferred Brand | 16% | 16% |
|
| RECOMBIVAX HB 40 ug/mL Injection, SuspensionHepatitis B Vaccine (Recombinant) | 3Preferred Brand | 16% | 16% |
|
| RECOMBIVAX HB 5 ug/.5mL Injection, SuspensionHepatitis B Vaccine (Recombinant) | 3Preferred Brand | 16% | 16% |
|
| RELENZA 5 mg PowderZanamivir | 3Preferred Brand | 16% | 16% |
|
| REPAGLINIDE .5 mg Tablet | 2Generic | $10.00 | $0.00 |
|
| REPAGLINIDE 1 mg Tablet | 2Generic | $10.00 | $0.00 |
|
| REPAGLINIDE 2 mg Tablet | 2Generic | $10.00 | $0.00 |
|
| REPATHA 140 mg/mL Injection, SolutionEvolocumab | 3Preferred Brand | 16% | 16% |
|
| REPATHA 140 mg/mL Injection, SolutionEvolocumab | 3Preferred Brand | 16% | 16% |
|
| RESTASIS .5 mg/mL EmulsionCyclosporine | 3Preferred Brand | 16% | 16% |
|
| RESTASIS MULTIDOSE .5 mg/mL EmulsionCyclosporine | 3Preferred Brand | 16% | 16% |
|
| RETEVMO 120 mg Tablet, CoatedSelpercatinib | 5Specialty Tier | 31% | N/A |
|
| RETEVMO 160 mg Tablet, CoatedSelpercatinib | 5Specialty Tier | 31% | N/A |
|
| RETEVMO 40 mg Tablet, CoatedSelpercatinib | 5Specialty Tier | 31% | N/A |
|
| RETEVMO 80 mg Tablet, CoatedSelpercatinib | 5Specialty Tier | 31% | N/A |
|
| REVCOVI 1.6 mg/mL InjectionElapegademase-Lvlr | 5Specialty Tier | 31% | N/A |
|
| REVUFORJ 110 mg Tablet, Film CoatedRevumenib | 5Specialty Tier | 31% | N/A |
|
| REVUFORJ 160 mg Tablet, Film CoatedRevumenib | 5Specialty Tier | 31% | N/A |
|
| REVUFORJ 25 mg Tablet, Film CoatedRevumenib | 5Specialty Tier | 31% | N/A |
|
| REXULTI .25 mg TabletBrexpiprazole | 4Non-Preferred Drug | 37% | N/A |
|
| REXULTI .5 mg TabletBrexpiprazole | 4Non-Preferred Drug | 37% | N/A |
|
| REXULTI 1 mg TabletBrexpiprazole | 4Non-Preferred Drug | 37% | N/A |
|
| REXULTI 2 mg TabletBrexpiprazole | 4Non-Preferred Drug | 37% | N/A |
|
| REXULTI 3 mg TabletBrexpiprazole | 4Non-Preferred Drug | 37% | N/A |
|
| REXULTI 4 mg TabletBrexpiprazole | 4Non-Preferred Drug | 37% | N/A |
|
| REYATAZ 50 mg PowderAtazanavir | 4Non-Preferred Drug | 37% | N/A |
|
| REZDIFFRA 100 mg Tablet, CoatedResmetirom | 5Specialty Tier | 31% | N/A |
|
| REZDIFFRA 60 mg Tablet, CoatedResmetirom | 5Specialty Tier | 31% | N/A |
|
| REZDIFFRA 80 mg Tablet, CoatedResmetirom | 5Specialty Tier | 31% | N/A |
|
| REZLIDHIA 150 mg CapsuleOlutasidenib | 5Specialty Tier | 31% | N/A |
|
| RHOPRESSA .2 mg/mL Solution/ DropsNetarsudil | 3Preferred Brand | 16% | 16% |
|
| RIBAVIRIN 200 mg Tablet, Film Coated | 3Preferred Brand | 16% | 16% | None |
| RIFABUTIN 150 mg Capsule | 4Non-Preferred Drug | 37% | N/A | None |
| RIFAMPIN 150 mg Capsule | 3Preferred Brand | 16% | 16% | None |
| RIFAMPIN 300 mg Capsule | 3Preferred Brand | 16% | 16% | None |
| RIFAMPIN 600 mg/10mL Injection, Powder, Lyophilized, For Solution | 4Non-Preferred Drug | 37% | N/A | None |
| RILUZOLE 50 mg Tablet | 3Preferred Brand | 16% | 16% | None |
| RIMANTADINE HYDROCHLORIDE 100 mg Tablet, Film Coated | 4Non-Preferred Drug | 37% | N/A | None |
| RINVOQ 1 mg/mL SolutionUpadacitinib | 5Specialty Tier | 31% | N/A |
|
| RINVOQ 15 mg Tablet, Extended ReleaseUpadacitinib | 5Specialty Tier | 31% | N/A |
|
| RINVOQ 30 mg Tablet, Extended ReleaseUpadacitinib | 5Specialty Tier | 31% | N/A |
|
| RINVOQ 45 mg Tablet, Extended ReleaseUpadacitinib | 5Specialty Tier | 31% | N/A |
|
| RISPERIDONE .25 mg Tablet | 2Generic | $10.00 | $0.00 | None |
| RISPERIDONE .25 mg Tablet, Orally Disintegrating | 4Non-Preferred Drug | 37% | N/A | None |
| RISPERIDONE .5 mg Tablet | 2Generic | $10.00 | $0.00 | None |
| RISPERIDONE .5 mg Tablet, Orally Disintegrating | 4Non-Preferred Drug | 37% | N/A | None |
| RISPERIDONE 1 mg Tablet | 2Generic | $10.00 | $0.00 | None |
| RISPERIDONE 1 mg Tablet, Orally Disintegrating | 4Non-Preferred Drug | 37% | N/A | None |
| RISPERIDONE 1 mg/mL Solution | 4Non-Preferred Drug | 37% | N/A | None |
| RISPERIDONE 2 mg Tablet | 2Generic | $10.00 | $0.00 | None |
| RISPERIDONE 2 mg Tablet, Orally Disintegrating | 4Non-Preferred Drug | 37% | N/A | None |
| RISPERIDONE 3 mg Tablet | 2Generic | $10.00 | $0.00 | None |
| RISPERIDONE 3 mg Tablet, Orally Disintegrating | 4Non-Preferred Drug | 37% | N/A | None |
| RISPERIDONE 4 mg Tablet | 2Generic | $10.00 | $0.00 | None |
| RISPERIDONE 4 mg Tablet, Orally Disintegrating | 4Non-Preferred Drug | 37% | N/A | None |
| RISPERIDONE Kit | 4Non-Preferred Drug | 37% | N/A | None |
| RISPERIDONE Kit | 4Non-Preferred Drug | 37% | N/A | None |
| RISPERIDONE Kit | 5Specialty Tier | 31% | N/A | None |
| RISPERIDONE Kit | 4Non-Preferred Drug | 37% | N/A | None |
| RITONAVIR 100 mg Tablet, Film Coated | 3Preferred Brand | 16% | 16% |
|
| RIVAROXABAN 2.5 mg Tablet, Film Coated | 3Preferred Brand | 16% | 16% |
|
| RIVASTIGMINE 13.3 mg/24h Patch | 4Non-Preferred Drug | 37% | N/A |
|
| RIVASTIGMINE 4.6 mg/24h Patch | 4Non-Preferred Drug | 37% | N/A |
|
| RIVASTIGMINE 9.5 mg/24h Patch | 4Non-Preferred Drug | 37% | N/A |
|
| RIVASTIGMINE TARTRATE 1.5 mg Capsule | 3Preferred Brand | 16% | 16% |
|
| RIVASTIGMINE TARTRATE 3 mg Capsule | 3Preferred Brand | 16% | 16% |
|
| RIVASTIGMINE TARTRATE 4.5 mg Capsule | 3Preferred Brand | 16% | 16% |
|
| RIVASTIGMINE TARTRATE 6 mg Capsule | 3Preferred Brand | 16% | 16% |
|
| RIVELSA KitLevonorgestrel/Ethinyl Estradiol And Ethinyl Estradiol | 3Preferred Brand | 16% | 16% | None |
| RIZATRIPTAN BENZOATE 10 mg Tablet | 3Preferred Brand | 16% | 16% |
|
| RIZATRIPTAN BENZOATE 10 mg Tablet, Orally Disintegrating | 3Preferred Brand | 16% | 16% |
|
| RIZATRIPTAN BENZOATE 5 mg Tablet | 3Preferred Brand | 16% | 16% |
|
| RIZATRIPTAN BENZOATE 5 mg Tablet, Orally Disintegrating | 3Preferred Brand | 16% | 16% |
|
| ROCKLATAN .2/.05 mg/mL Solution/ DropsNetarsudil And Latanoprost Ophthalmic Solution, 0.02%/0.005% | 3Preferred Brand | 16% | 16% |
|
| ROFLUMILAST 250 ug Tablet | 4Non-Preferred Drug | 37% | N/A |
|
| ROFLUMILAST 500 ug Tablet | 4Non-Preferred Drug | 37% | N/A |
|
| ROMVIMZA 14 mg CapsuleVimseltinib | 5Specialty Tier | 31% | N/A |
|
| ROMVIMZA 20 mg CapsuleVimseltinib | 5Specialty Tier | 31% | N/A |
|
| ROMVIMZA 30 mg CapsuleVimseltinib | 5Specialty Tier | 31% | N/A |
|
| ROPINIROLE 1 mg Tablet, Film Coated | 2Generic | $10.00 | $0.00 | None |
| ROPINIROLE 2 mg Tablet, Film Coated | 2Generic | $10.00 | $0.00 | None |
| ROPINIROLE HYDROCHLORIDE .25 mg Tablet, Film Coated | 2Generic | $10.00 | $0.00 | None |
| ROPINIROLE HYDROCHLORIDE .5 mg Tablet, Film Coated | 2Generic | $10.00 | $0.00 | None |
| ROPINIROLE HYDROCHLORIDE 3 mg Tablet, Film Coated | 2Generic | $10.00 | $0.00 | None |
| ROPINIROLE HYDROCHLORIDE 4 mg Tablet, Film Coated | 2Generic | $10.00 | $0.00 | None |
| ROPINIROLE HYDROCHLORIDE 5 mg Tablet, Film Coated | 2Generic | $10.00 | $0.00 | None |
| ROSUVASTATIN 40 mg Tablet, Film Coated | 1Preferred Generic | $5.00 | $0.00 |
|
| ROSUVASTATIN CALCIUM 10 mg Tablet, Film Coated | 1Preferred Generic | $5.00 | $0.00 |
|
| ROSUVASTATIN CALCIUM 20 mg Tablet, Film Coated | 1Preferred Generic | $5.00 | $0.00 |
|
| ROSUVASTATIN CALCIUM 5 mg Tablet, Film Coated | 1Preferred Generic | $5.00 | $0.00 |
|
| ROSYRAH KitLevonorgestrel And Ethinyl Estradiol And Ethinyl Estradiol | 3Preferred Brand | 16% | 16% | None |
| ROTATEQ 2200000/2800000/2200000/2000000/2300000 [iU]/2mL SolutionRotavirus Vaccine, Live, Oral, Pentavalent | 3Preferred Brand | 16% | 16% |
|
| ROZLYTREK 100 mg CapsuleEntrectinib | 5Specialty Tier | 31% | N/A |
|
| ROZLYTREK 200 mg CapsuleEntrectinib | 5Specialty Tier | 31% | N/A |
|
| ROZLYTREK 50 mg/201 PelletEntrectinib | 5Specialty Tier | 31% | N/A |
|
| RUBRACA 200 mg Tablet, Film CoatedRucaparib | 5Specialty Tier | 31% | N/A |
|
| RUBRACA 250 mg Tablet, Film CoatedRucaparib | 5Specialty Tier | 31% | N/A |
|
| RUBRACA 300 mg Tablet, Film CoatedRucaparib | 5Specialty Tier | 31% | N/A |
|
| RUFINAMIDE 200 mg Tablet, Film Coated | 4Non-Preferred Drug | 37% | N/A | None |
| RUFINAMIDE 40 mg/mL Suspension | 4Non-Preferred Drug | 37% | N/A | None |
| RUFINAMIDE 400 mg Tablet, Film Coated | 4Non-Preferred Drug | 37% | N/A | None |
| RUKOBIA 600 mg Tablet, Film Coated, Extended ReleaseFostemsavir Tromethamine | 5Specialty Tier | 31% | N/A |
|
| RYALTRIS 665/25 ug Spray, MeteredOlopatadine Hydrochloride And Mometasone Furoate | 3Preferred Brand | 16% | 16% | None |
| RYBELSUS 14 mg TabletOral Semaglutide | 3Preferred Brand | 16% | 16% |
|
| RYBELSUS 3 mg TabletOral Semaglutide | 3Preferred Brand | 16% | 16% |
|
| RYBELSUS 7 mg TabletOral Semaglutide | 3Preferred Brand | 16% | 16% |
|
| RYDAPT 25 mg Capsule, Liquid Filled | 5Specialty Tier | 31% | N/A |
|
PA = prior authorization, ST = step therapy, QL = quantity limit. Costs are the plan’s initial-coverage cost-sharing from the CMS 2026 formulary files; a drug not listed here is not on this plan’s formulary, though a formulary exception may still be possible.